The role of endothelial activation in dengue hemorrhagic fever and hantavirus pulmonary syndrome

References

• Moraz ML, Kunz S. Pathogenesis of arenavirus hemorrhagic fevers. Expert Rev Anti Infect Ther 2011; 9:49 - 59; http://dx.doi.org/10.1586/eri.10.142; PMID: 21171877
   PubMed Web of Science ®Google Scholar
• Wahl-Jensen VM, Afanasieva TA, Seebach J, Ströher U, Feldmann H, Schnittler HJ. Effects of Ebola virus glycoproteins on endothelial cell activation and barrier function. J Virol 2005; 79:10442 - 50; http://dx.doi.org/10.1128/JVI.79.16.10442-10450.2005; PMID: 16051836
   PubMed Web of Science ®Google Scholar
• Yang ZY, Duckers HJ, Sullivan NJ, Sanchez A, Nabel EG, Nabel GJ. Identification of the Ebola virus glycoprotein as the main viral determinant of vascular cell cytotoxicity and injury. Nat Med 2000; 6:886 - 9; http://dx.doi.org/10.1038/78645; PMID: 10932225
   PubMed Web of Science ®Google Scholar
• Mongkolsapaya J, Dejnirattisai W, Xu XN, Vasanawathana S, Tangthawornchaikul N, Chairunsri A, et al. Original antigenic sin and apoptosis in the pathogenesis of dengue hemorrhagic fever. Nat Med 2003; 9:921 - 7; http://dx.doi.org/10.1038/nm887; PMID: 12808447
   PubMed Web of Science ®Google Scholar
• Amarasinghe A, Letson GW. Dengue in the Middle East: a neglected, emerging disease of importance. Trans R Soc Trop Med Hyg 2012; 106:1 - 2; http://dx.doi.org/10.1016/j.trstmh.2011.08.014; PMID: 22137535
   PubMed Web of Science ®Google Scholar
• Baruah K, Singh PK, Mohalia MM, Dhariwal AC. A study on dengue outbreak during 2009 in Bhopal and Indore districts of Madhya Pradesh, India. J Commun Dis 2010; 42:273 - 9; PMID: 22471197
   PubMedGoogle Scholar
• Sinha N, Gupta N, Jhamb R, Gulati S, Kulkarni Ajit V. The 2006 dengue outbreak in Delhi, India. J Commun Dis 2008; 40:243 - 8; PMID: 19579715
   PubMedGoogle Scholar
• Franco C, Hynes NA, Bouri N, Henderson DA. The dengue threat to the United States. Biosecur Bioterror 2010; 8:273 - 6; http://dx.doi.org/10.1089/bsp.2010.0032; PMID: 20718665
   PubMed Web of Science ®Google Scholar
• Morens DM, Fauci AS. Dengue and hemorrhagic fever: a potential threat to public health in the United States. JAMA 2008; 299:214 - 6; http://dx.doi.org/10.1001/jama.2007.31-a; PMID: 18182605
   PubMed Web of Science ®Google Scholar
• Gubler D, Kuno G, Markoff L. Flavivirus, Field’s Virology. Lippincott Williams & Wilkins, 2007.
   Google Scholar
• Aguirre S, Maestre AM, Pagni S, Patel JR, Savage T, Gutman D, et al. DENV inhibits type I IFN production in infected cells by cleaving human STING. PLoS Pathog 2012; 8:e1002934; http://dx.doi.org/10.1371/journal.ppat.1002934; PMID: 23055924
   PubMed Web of Science ®Google Scholar
• Muñoz-Jordán JL, Laurent-Rolle M, Ashour J, Martínez-Sobrido L, Ashok M, Lipkin WI, et al. Inhibition of alpha/beta interferon signaling by the NS4B protein of flaviviruses. J Virol 2005; 79:8004 - 13; http://dx.doi.org/10.1128/JVI.79.13.8004-8013.2005; PMID: 15956546
   PubMed Web of Science ®Google Scholar
• Endy TP, Chunsuttiwat S, Nisalak A, Libraty DH, Green S, Rothman AL, et al. Epidemiology of inapparent and symptomatic acute dengue virus infection: a prospective study of primary school children in Kamphaeng Phet, Thailand. Am J Epidemiol 2002; 156:40 - 51; http://dx.doi.org/10.1093/aje/kwf005; PMID: 12076887
   PubMed Web of Science ®Google Scholar
• Srikiatkhachorn A, Green S. Markers of dengue disease severity. Curr Top Microbiol Immunol 2010; 338:67 - 82; http://dx.doi.org/10.1007/978-3-642-02215-9_6; PMID: 19802579
   PubMed Web of Science ®Google Scholar
• WHO. Dengue hemorrhagic fever: diagnosis, treatment, prevention and control. Geneva: WHO, 1997.
   Google Scholar
• Cam BV, Fonsmark L, Hue NB, Phuong NT, Poulsen A, Heegaard ED. Prospective case-control study of encephalopathy in children with dengue hemorrhagic fever. Am J Trop Med Hyg 2001; 65:848 - 51; PMID: 11791985
   PubMed Web of Science ®Google Scholar
• Marques N, Gan VC, Leo YS. Dengue myocarditis in Singapore: two case reports. Infection 2013; 41:709 - 14; http://dx.doi.org/10.1007/s15010-012-0392-9; PMID: 23277366
   PubMed Web of Science ®Google Scholar
• Alexander N, Balmaseda A, Coelho IC, Dimaano E, Hien TT, Hung NT, et al, European Union, World Health Organization (WHO‐TDR) supported DENCO Study Group. Multicentre prospective study on dengue classification in four South-east Asian and three Latin American countries. Trop Med Int Health 2011; 16:936 - 48; http://dx.doi.org/10.1111/j.1365-3156.2011.02793.x; PMID: 21624014
   PubMed Web of Science ®Google Scholar
• Sumarmo TW, Talogo W, Asrin A, Isnuhandojo B, Sahudi A. Failure of hydrocortisone to affect outcome in dengue shock syndrome. Pediatrics 1982; 69:45 - 9; PMID: 7054760
   PubMed Web of Science ®Google Scholar
• Tam DT, Ngoc TV, Tien NT, Kieu NT, Thuy TT, Thanh LT, et al. Effects of short-course oral corticosteroid therapy in early dengue infection in Vietnamese patients: a randomized, placebo-controlled trial. Clin Infect Dis 2012; 55:1216 - 24; http://dx.doi.org/10.1093/cid/cis655; PMID: 22865871
   PubMed Web of Science ®Google Scholar
• Tassniyom S, Vasanawathana S, Chirawatkul A, Rojanasuphot S. Failure of high-dose methylprednisolone in established dengue shock syndrome: a placebo-controlled, double-blind study. Pediatrics 1993; 92:111 - 5; PMID: 8516054
   PubMed Web of Science ®Google Scholar
• Burke DS, Nisalak A, Johnson DE, Scott RM. A prospective study of dengue infections in Bangkok. Am J Trop Med Hyg 1988; 38:172 - 80; PMID: 3341519
   PubMed Web of Science ®Google Scholar
• Bravo JR, Guzmán MG, Kouri GP. Why dengue haemorrhagic fever in Cuba? 1. Individual risk factors for dengue haemorrhagic fever/dengue shock syndrome (DHF/DSS). Trans R Soc Trop Med Hyg 1987; 81:816 - 20; http://dx.doi.org/10.1016/0035-9203(87)90041-1; PMID: 3450004
   PubMed Web of Science ®Google Scholar
• Halstead SB. In vivo enhancement of dengue virus infection in rhesus monkeys by passively transferred antibody. J Infect Dis 1979; 140:527 - 33; http://dx.doi.org/10.1093/infdis/140.4.527; PMID: 117061
   PubMed Web of Science ®Google Scholar
• Halstead SB. Antibody, macrophages, dengue virus infection, shock, and hemorrhage: a pathogenetic cascade. Rev Infect Dis 1989; 11:Suppl 4 S830 - 9; http://dx.doi.org/10.1093/clinids/11.Supplement_4.S830; PMID: 2665015
   PubMedGoogle Scholar
• Stephens HA. HLA and other gene associations with dengue disease severity. Curr Top Microbiol Immunol 2010; 338:99 - 114; http://dx.doi.org/10.1007/978-3-642-02215-9_8; PMID: 19802581
   PubMed Web of Science ®Google Scholar
• Perez AB, Sierra B, Garcia G, Aguirre E, Babel N, Alvarez M, et al. Tumor necrosis factor-alpha, transforming growth factor-β1, and interleukin-10 gene polymorphisms: implication in protection or susceptibility to dengue hemorrhagic fever. Hum Immunol 2010; 71:1135 - 40; http://dx.doi.org/10.1016/j.humimm.2010.08.004; PMID: 20732366
   PubMed Web of Science ®Google Scholar
• OhAinle M, Balmaseda A, Macalalad AR, Tellez Y, Zody MC, Saborío S, et al. Dynamics of dengue disease severity determined by the interplay between viral genetics and serotype-specific immunity. Sci Transl Med 2011; 3:ra128; http://dx.doi.org/10.1126/scitranslmed.3003084; PMID: 22190239
   PubMed Web of Science ®Google Scholar
• Rico-Hesse R, Harrison LM, Salas RA, Tovar D, Nisalak A, Ramos C, et al. Origins of dengue type 2 viruses associated with increased pathogenicity in the Americas. Virology 1997; 230:244 - 51; http://dx.doi.org/10.1006/viro.1997.8504; PMID: 9143280
   PubMed Web of Science ®Google Scholar
• Leitmeyer KC, Vaughn DW, Watts DM, Salas R, Villalobos I, de Chacon, et al. Dengue virus structural differences that correlate with pathogenesis. J Virol 1999; 73:4738 - 47; PMID: 10233934
   PubMed Web of Science ®Google Scholar
• Grant D, Tan GK, Qing M, Ng JK, Yip A, Zou G, et al. A single amino acid in nonstructural protein NS4B confers virulence to dengue virus in AG129 mice through enhancement of viral RNA synthesis. J Virol 2011; 85:7775 - 87; http://dx.doi.org/10.1128/JVI.00665-11; PMID: 21632767
   PubMed Web of Science ®Google Scholar
• Wu SJ, Grouard-Vogel G, Sun W, Mascola JR, Brachtel E, Putvatana R, et al. Human skin Langerhans cells are targets of dengue virus infection. Nat Med 2000; 6:816 - 20; http://dx.doi.org/10.1038/77553; PMID: 10888933
   PubMed Web of Science ®Google Scholar
• Taweechaisupapong S, Sriurairatana S, Angsubhakorn S, Yoksan S, Bhamarapravati N. In vivo and in vitro studies on the morphological change in the monkey epidermal Langerhans cells following exposure to dengue 2 (16681) virus. Southeast Asian J Trop Med Public Health 1996; 27:664 - 72; PMID: 9253864
   PubMedGoogle Scholar
• Limon-Flores AY, Perez-Tapia M, Estrada-Garcia I, Vaughan G, Escobar-Gutierrez A, Calderon-Amador J, et al. Dengue virus inoculation to human skin explants: an effective approach to assess in situ the early infection and the effects on cutaneous dendritic cells. Int J Exp Pathol 2005; 86:323 - 34; http://dx.doi.org/10.1111/j.0959-9673.2005.00445.x; PMID: 16191104
   PubMed Web of Science ®Google Scholar
• Tassaneetrithep B, Burgess TH, Granelli-Piperno A, Trumpfheller C, Finke J, Sun W, et al. DC-SIGN (CD209) mediates dengue virus infection of human dendritic cells. J Exp Med 2003; 197:823 - 9; http://dx.doi.org/10.1084/jem.20021840; PMID: 12682107
   PubMed Web of Science ®Google Scholar
• Chen ST, Lin YL, Huang MT, Wu MF, Cheng SC, Lei HY, et al. CLEC5A is critical for dengue-virus-induced lethal disease. Nature 2008; 453:672 - 6; http://dx.doi.org/10.1038/nature07013; PMID: 18496526
   PubMed Web of Science ®Google Scholar
• Watson AA, Lebedev AA, Hall BA, Fenton-May AE, Vagin AA, Dejnirattisai W, et al. Structural flexibility of the macrophage dengue virus receptor CLEC5A: implications for ligand binding and signaling. J Biol Chem 2011; 286:24208 - 18; http://dx.doi.org/10.1074/jbc.M111.226142; PMID: 21566123
   PubMed Web of Science ®Google Scholar
• Balsitis SJ, Coloma J, Castro G, Alava A, Flores D, McKerrow JH, et al. Tropism of dengue virus in mice and humans defined by viral nonstructural protein 3-specific immunostaining. Am J Trop Med Hyg 2009; 80:416 - 24; PMID: 19270292
   PubMed Web of Science ®Google Scholar
• Jessie K, Fong MY, Devi S, Lam SK, Wong KT. Localization of dengue virus in naturally infected human tissues, by immunohistochemistry and in situ hybridization. J Infect Dis 2004; 189:1411 - 8; http://dx.doi.org/10.1086/383043; PMID: 15073678
   PubMed Web of Science ®Google Scholar
• Bhamarapravati N, Tuchinda P, Boonyapaknavik V. Pathology of Thailand haemorrhagic fever: a study of 100 autopsy cases. Ann Trop Med Parasitol 1967; 61:500 - 10; PMID: 5634140
   PubMed Web of Science ®Google Scholar
• Limonta D, Capó V, Torres G, Pérez AB, Guzmán MG. Apoptosis in tissues from fatal dengue shock syndrome. J Clin Virol 2007; 40:50 - 4; http://dx.doi.org/10.1016/j.jcv.2007.04.024; PMID: 17693133
   PubMed Web of Science ®Google Scholar
• Kangwanpong D, Bhamarapravati N, Lucia HL. Diagnosing dengue virus infection in archived autopsy tissues by means of the in situ PCR method: a case report. Clin Diagn Virol 1995; 3:165 - 72; http://dx.doi.org/10.1016/0928-0197(94)00032-P; PMID: 15566798
   PubMedGoogle Scholar
• Couvelard A, Marianneau P, Bedel C, Drouet MT, Vachon F, Hénin D, et al. Report of a fatal case of dengue infection with hepatitis: demonstration of dengue antigens in hepatocytes and liver apoptosis. Hum Pathol 1999; 30:1106 - 10; http://dx.doi.org/10.1016/S0046-8177(99)90230-7; PMID: 10492047
   PubMed Web of Science ®Google Scholar
• Kalayanarooj S, Vaughn DW, Nimmannitya S, Green S, Suntayakorn S, Kunentrasai N, et al. Early clinical and laboratory indicators of acute dengue illness. J Infect Dis 1997; 176:313 - 21; http://dx.doi.org/10.1086/514047; PMID: 9237695
   PubMed Web of Science ®Google Scholar
• Libraty DH, Endy TP, Houng HS, Green S, Kalayanarooj S, Suntayakorn S, et al. Differing influences of virus burden and immune activation on disease severity in secondary dengue-3 virus infections. J Infect Dis 2002; 185:1213 - 21; http://dx.doi.org/10.1086/340365; PMID: 12001037
   PubMed Web of Science ®Google Scholar
• Libraty DH, Young PR, Pickering D, Endy TP, Kalayanarooj S, Green S, et al. High circulating levels of the dengue virus nonstructural protein NS1 early in dengue illness correlate with the development of dengue hemorrhagic fever. J Infect Dis 2002; 186:1165 - 8; http://dx.doi.org/10.1086/343813; PMID: 12355369
   PubMed Web of Science ®Google Scholar
• Vaughn DW, Green S, Kalayanarooj S, Innis BL, Nimmannitya S, Suntayakorn S, et al. Dengue viremia titer, antibody response pattern, and virus serotype correlate with disease severity. J Infect Dis 2000; 181:2 - 9; http://dx.doi.org/10.1086/315215; PMID: 10608744
   PubMed Web of Science ®Google Scholar
• Dejnirattisai W, Jumnainsong A, Onsirisakul N, Fitton P, Vasanawathana S, Limpitikul W, et al. Cross-reacting antibodies enhance dengue virus infection in humans. Science 2010; 328:745 - 8; http://dx.doi.org/10.1126/science.1185181; PMID: 20448183
   PubMed Web of Science ®Google Scholar
• Srikiatkhachorn A, Wichit S, Gibbons RV, Green S, Libraty DH, Endy TP, et al. Dengue viral RNA levels in peripheral blood mononuclear cells are associated with disease severity and preexisting dengue immune status. PLoS One 2012; 7:e51335; http://dx.doi.org/10.1371/journal.pone.0051335; PMID: 23284680
   PubMed Web of Science ®Google Scholar
• Ubol S, Phuklia W, Kalayanarooj S, Modhiran N. Mechanisms of immune evasion induced by a complex of dengue virus and preexisting enhancing antibodies. J Infect Dis 2010; 201:923 - 35; http://dx.doi.org/10.1086/651018; PMID: 20158392
   PubMed Web of Science ®Google Scholar
• Modhiran N, Kalayanarooj S, Ubol S. Subversion of innate defenses by the interplay between DENV and pre-existing enhancing antibodies: TLRs signaling collapse. PLoS Negl Trop Dis 2010; 4:e924; http://dx.doi.org/10.1371/journal.pntd.0000924; PMID: 21200427
   PubMed Web of Science ®Google Scholar
• Green S, Vaughn DW, Kalayanarooj S, Nimmannitya S, Suntayakorn S, Nisalak A, et al. Elevated plasma interleukin-10 levels in acute dengue correlate with disease severity. J Med Virol 1999; 59:329 - 34; http://dx.doi.org/10.1002/(SICI)1096-9071(199911)59:3<329::AID-JMV12>3.0.CO;2-G; PMID: 10502265
   PubMed Web of Science ®Google Scholar
• Mangada MM, Rothman AL. Altered cytokine responses of dengue-specific CD4+ T cells to heterologous serotypes. J Immunol 2005; 175:2676 - 83; PMID: 16081844
   PubMed Web of Science ®Google Scholar
• Friberg H, Burns L, Woda M, Kalayanarooj S, Endy TP, Stephens HA, et al. Memory CD8+ T cells from naturally acquired primary dengue virus infection are highly cross-reactive. Immunol Cell Biol 2011; 89:122 - 9; http://dx.doi.org/10.1038/icb.2010.61; PMID: 20421879
   PubMed Web of Science ®Google Scholar
• Mongkolsapaya J, Duangchinda T, Dejnirattisai W, Vasanawathana S, Avirutnan P, Jairungsri A, et al. T cell responses in dengue hemorrhagic fever: are cross-reactive T cells suboptimal?. J Immunol 2006; 176:3821 - 9; PMID: 16517753
   PubMed Web of Science ®Google Scholar
• Nasirudeen AM, Wong HH, Thien P, Xu S, Lam KP, Liu DX. RIG-I, MDA5 and TLR3 synergistically play an important role in restriction of dengue virus infection. PLoS Negl Trop Dis 2011; 5:e926; http://dx.doi.org/10.1371/journal.pntd.0000926; PMID: 21245912
   PubMed Web of Science ®Google Scholar
• Jones M, Davidson A, Hibbert L, Gruenwald P, Schlaak J, Ball S, et al. Dengue virus inhibits alpha interferon signaling by reducing STAT2 expression. J Virol 2005; 79:5414 - 20; http://dx.doi.org/10.1128/JVI.79.9.5414-5420.2005; PMID: 15827155
   PubMed Web of Science ®Google Scholar
• Yu CY, Chang TH, Liang JJ, Chiang RL, Lee YL, Liao CL, et al. Dengue virus targets the adaptor protein MITA to subvert host innate immunity. PLoS Pathog 2012; 8:e1002780; http://dx.doi.org/10.1371/journal.ppat.1002780; PMID: 22761576
   PubMed Web of Science ®Google Scholar
• Ashour J, Morrison J, Laurent-Rolle M, Belicha-Villanueva A, Plumlee CR, Bernal-Rubio D, et al. Mouse STAT2 restricts early dengue virus replication. Cell Host Microbe 2010; 8:410 - 21; http://dx.doi.org/10.1016/j.chom.2010.10.007; PMID: 21075352
   PubMed Web of Science ®Google Scholar
• Rodriguez-Madoz JR, Belicha-Villanueva A, Bernal-Rubio D, Ashour J, Ayllon J, Fernandez-Sesma A. Inhibition of the type I interferon response in human dendritic cells by dengue virus infection requires a catalytically active NS2B3 complex. J Virol 2010; 84:9760 - 74; http://dx.doi.org/10.1128/JVI.01051-10; PMID: 20660196
   PubMed Web of Science ®Google Scholar
• Bosch I, Xhaja K, Estevez L, Raines G, Melichar H, Warke RV, et al. Increased production of interleukin-8 in primary human monocytes and in human epithelial and endothelial cell lines after dengue virus challenge. J Virol 2002; 76:5588 - 97; http://dx.doi.org/10.1128/JVI.76.11.5588-5597.2002; PMID: 11991987
   PubMed Web of Science ®Google Scholar
• Dejnirattisai W, Duangchinda T, Lin CL, Vasanawathana S, Jones M, Jacobs M, et al. A complex interplay among virus, dendritic cells, T cells, and cytokines in dengue virus infections. J Immunol 2008; 181:5865 - 74; PMID: 18941175
   PubMed Web of Science ®Google Scholar
• Huang KJ, Li SY, Chen SC, Liu HS, Lin YS, Yeh TM, et al. Manifestation of thrombocytopenia in dengue-2-virus-infected mice. J Gen Virol 2000; 81:2177 - 82; PMID: 10950974
   PubMed Web of Science ®Google Scholar
• Avirutnan P, Malasit P, Seliger B, Bhakdi S, Husmann M. Dengue virus infection of human endothelial cells leads to chemokine production, complement activation, and apoptosis. J Immunol 1998; 161:6338 - 46; PMID: 9834124
   PubMed Web of Science ®Google Scholar
• Azeredo EL, Zagne SM, Alvarenga AR, Nogueira RM, Kubelka CF, de Oliveira-Pinto LM. Activated peripheral lymphocytes with increased expression of cell adhesion molecules and cytotoxic markers are associated with dengue fever disease. Mem Inst Oswaldo Cruz 2006; 101:437 - 49; http://dx.doi.org/10.1590/S0074-02762006000400016; PMID: 16951817
   PubMed Web of Science ®Google Scholar
• Braga EL, Moura P, Pinto LM, Ignácio SR, Oliveira MJ, Cordeiro MT, et al. Detection of circulant tumor necrosis factor-alpha, soluble tumor necrosis factor p75 and interferon-gamma in Brazilian patients with dengue fever and dengue hemorrhagic fever. Mem Inst Oswaldo Cruz 2001; 96:229 - 32; http://dx.doi.org/10.1590/S0074-02762001000200015; PMID: 11285501
   PubMed Web of Science ®Google Scholar
• Bashyam HS, Green S, Rothman AL. Dengue virus-reactive CD8+ T cells display quantitative and qualitative differences in their response to variant epitopes of heterologous viral serotypes. J Immunol 2006; 176:2817 - 24; PMID: 16493038
   PubMed Web of Science ®Google Scholar
• Bozza FA, Cruz OG, Zagne SM, Azeredo EL, Nogueira RM, Assis EF, et al. Multiplex cytokine profile from dengue patients: MIP-1beta and IFN-gamma as predictive factors for severity. BMC Infect Dis 2008; 8:86; http://dx.doi.org/10.1186/1471-2334-8-86; PMID: 18578883
   PubMed Web of Science ®Google Scholar
• Butthep P, Chunhakan S, Yoksan S, Tangnararatchakit K, Chuansumrit A. Alteration of cytokines and chemokines during febrile episodes associated with endothelial cell damage and plasma leakage in dengue hemorrhagic fever. Pediatr Infect Dis J 2012; 31:e232 - 8; http://dx.doi.org/10.1097/INF.0b013e31826fd456; PMID: 22926216
   PubMed Web of Science ®Google Scholar
• Mota J, Rico-Hesse R. Humanized mice show clinical signs of dengue fever according to infecting virus genotype. J Virol 2009; 83:8638 - 45; http://dx.doi.org/10.1128/JVI.00581-09; PMID: 19535452
   PubMed Web of Science ®Google Scholar
• Shresta S, Sharar KL, Prigozhin DM, Beatty PR, Harris E. Murine model for dengue virus-induced lethal disease with increased vascular permeability. J Virol 2006; 80:10208 - 17; http://dx.doi.org/10.1128/JVI.00062-06; PMID: 17005698
   PubMed Web of Science ®Google Scholar
• Wu-Hsieh BA, Yen YT, Chen HC. Dengue hemorrhage in a mouse model. Ann N Y Acad Sci 2009; 1171:Suppl 1 E42 - 7; http://dx.doi.org/10.1111/j.1749-6632.2009.05053.x; PMID: 19751401
   PubMedGoogle Scholar
• Srikiatkhachorn A, Ajariyakhajorn C, Endy TP, Kalayanarooj S, Libraty DH, Green S, et al. Virus-induced decline in soluble vascular endothelial growth receptor 2 is associated with plasma leakage in dengue hemorrhagic Fever. J Virol 2007; 81:1592 - 600; http://dx.doi.org/10.1128/JVI.01642-06; PMID: 17151115
   PubMed Web of Science ®Google Scholar
• Zhang JL, Wang JL, Gao N, Chen ZT, Tian YP, An J. Up-regulated expression of beta3 integrin induced by dengue virus serotype 2 infection associated with virus entry into human dermal microvascular endothelial cells. Biochem Biophys Res Commun 2007; 356:763 - 8; http://dx.doi.org/10.1016/j.bbrc.2007.03.051; PMID: 17382900
   PubMed Web of Science ®Google Scholar
• Cardier JE, Rivas B, Romano E, Rothman AL, Perez-Perez C, Ochoa M, et al. Evidence of vascular damage in dengue disease: demonstration of high levels of soluble cell adhesion molecules and circulating endothelial cells. Endothelium 2006; 13:335 - 40; http://dx.doi.org/10.1080/10623320600972135; PMID: 17090406
   PubMed Web of Science ®Google Scholar
• Koraka P, Murgue B, Deparis X, Van Gorp EC, Setiati TE, Osterhaus AD, et al. Elevation of soluble VCAM-1 plasma levels in children with acute dengue virus infection of varying severity. J Med Virol 2004; 72:445 - 50; http://dx.doi.org/10.1002/jmv.20007; PMID: 14748068
   PubMed Web of Science ®Google Scholar
• Michels M, van der Ven AJ, Djamiatun K, Fijnheer R, de Groot PG, Griffioen AW, et al. Imbalance of angiopoietin-1 and angiopoetin-2 in severe dengue and relationship with thrombocytopenia, endothelial activation, and vascular stability. Am J Trop Med Hyg 2012; 87:943 - 6; http://dx.doi.org/10.4269/ajtmh.2012.12-0020; PMID: 22949515
   PubMed Web of Science ®Google Scholar
• Parikh SM, Mammoto T, Schultz A, Yuan HT, Christiani D, Karumanchi SA, et al. Excess circulating angiopoietin-2 may contribute to pulmonary vascular leak in sepsis in humans. PLoS Med 2006; 3:e46; http://dx.doi.org/10.1371/journal.pmed.0030046; PMID: 16417407
   PubMedGoogle Scholar
• Ricciuto DR, dos Santos CC, Hawkes M, Toltl LJ, Conroy AL, Rajwans N, et al. Angiopoietin-1 and angiopoietin-2 as clinically informative prognostic biomarkers of morbidity and mortality in severe sepsis. Crit Care Med 2011; 39:702 - 10; http://dx.doi.org/10.1097/CCM.0b013e318206d285; PMID: 21242795
   PubMed Web of Science ®Google Scholar
• Dewi BE, Takasaki T, Kurane I. In vitro assessment of human endothelial cell permeability: effects of inflammatory cytokines and dengue virus infection. J Virol Methods 2004; 121:171 - 80; http://dx.doi.org/10.1016/j.jviromet.2004.06.013; PMID: 15381354
   PubMed Web of Science ®Google Scholar
• Kelley JF, Kaufusi PH, Nerurkar VR. Dengue hemorrhagic fever-associated immunomediators induced via maturation of dengue virus nonstructural 4B protein in monocytes modulate endothelial cell adhesion molecules and human microvascular endothelial cells permeability. Virology 2012; 422:326 - 37; http://dx.doi.org/10.1016/j.virol.2011.10.030; PMID: 22129847
   PubMed Web of Science ®Google Scholar
• Lee YR, Liu MT, Lei HY, Liu CC, Wu JM, Tung YC, et al. MCP-1, a highly expressed chemokine in dengue haemorrhagic fever/dengue shock syndrome patients, may cause permeability change, possibly through reduced tight junctions of vascular endothelium cells. J Gen Virol 2006; 87:3623 - 30; http://dx.doi.org/10.1099/vir.0.82093-0; PMID: 17098977
   PubMed Web of Science ®Google Scholar
• Luplertlop N, Missé D, Bray D, Deleuze V, Gonzalez JP, Leardkamolkarn V, et al. Dengue-virus-infected dendritic cells trigger vascular leakage through metalloproteinase overproduction. EMBO Rep 2006; 7:1176 - 81; http://dx.doi.org/10.1038/sj.embor.7400814; PMID: 17028575
   PubMed Web of Science ®Google Scholar
• Sosothikul D, Seksarn P, Pongsewalak S, Thisyakorn U, Lusher J. Activation of endothelial cells, coagulation and fibrinolysis in children with Dengue virus infection. Thromb Haemost 2007; 97:627 - 34; PMID: 17393026
   PubMed Web of Science ®Google Scholar
• Wills BA, Oragui EE, Stephens AC, Daramola OA, Dung NM, Loan HT, et al. Coagulation abnormalities in dengue hemorrhagic Fever: serial investigations in 167 Vietnamese children with Dengue shock syndrome. Clin Infect Dis 2002; 35:277 - 85; http://dx.doi.org/10.1086/341410; PMID: 12115093
   PubMed Web of Science ®Google Scholar
• Djamiatun K, van der Ven AJ, de Groot PG, Faradz SM, Hapsari D, Dolmans WM, et al. Severe dengue is associated with consumption of von Willebrand factor and its cleaving enzyme ADAMTS-13. PLoS Negl Trop Dis 2012; 6:e1628; http://dx.doi.org/10.1371/journal.pntd.0001628; PMID: 22563509
   PubMed Web of Science ®Google Scholar
• Cabello-Gutiérrez C, Manjarrez-Zavala ME, Huerta-Zepeda A, Cime-Castillo J, Monroy-Martínez V, Correa BB, et al. Modification of the cytoprotective protein C pathway during Dengue virus infection of human endothelial vascular cells. Thromb Haemost 2009; 101:916 - 28; PMID: 19404546
   PubMed Web of Science ®Google Scholar
• Huerta-Zepeda A, Cabello-Gutiérrez C, Cime-Castillo J, Monroy-Martínez V, Manjarrez-Zavala ME, Gutiérrez-Rodríguez M, et al. Crosstalk between coagulation and inflammation during Dengue virus infection. Thromb Haemost 2008; 99:936 - 43; PMID: 18449425
   PubMed Web of Science ®Google Scholar
• Jiang Z, Tang X, Xiao R, Jiang L, Chen X. Dengue virus regulates the expression of hemostasis-related molecules in human vein endothelial cells. J Infect 2007; 55:e23 - 8; http://dx.doi.org/10.1016/j.jinf.2007.04.351; PMID: 17573116
   PubMedGoogle Scholar
• Chuang YC, Lei HY, Lin YS, Liu HS, Wu HL, Yeh TM. Dengue virus-induced autoantibodies bind to plasminogen and enhance its activation. J Immunol 2011; 187:6483 - 90; http://dx.doi.org/10.4049/jimmunol.1102218; PMID: 22079981
   PubMed Web of Science ®Google Scholar
• Lin CF, Lei HY, Shiau AL, Liu CC, Liu HS, Yeh TM, et al. Antibodies from dengue patient sera cross-react with endothelial cells and induce damage. J Med Virol 2003; 69:82 - 90; http://dx.doi.org/10.1002/jmv.10261; PMID: 12436482
   PubMed Web of Science ®Google Scholar
• Lin CF, Lei HY, Shiau AL, Liu HS, Yeh TM, Chen SH, et al. Endothelial cell apoptosis induced by antibodies against dengue virus nonstructural protein 1 via production of nitric oxide. J Immunol 2002; 169:657 - 64; PMID: 12097367
   PubMed Web of Science ®Google Scholar
• Lin YS, Yeh TM, Lin CF, Wan SW, Chuang YC, Hsu TK, et al. Molecular mimicry between virus and host and its implications for dengue disease pathogenesis. Exp Biol Med (Maywood) 2011; 236:515 - 23; http://dx.doi.org/10.1258/ebm.2011.010339; PMID: 21502191
   PubMed Web of Science ®Google Scholar
• Schmaljohn CS, Nichol ST. Bunyaviridae. In: Knipe DM, Howley PM, eds. Fields Virology. 5th ed. Philadelphia, Pa: Lippincott-Raven, 2007:1741-89.
   Google Scholar
• Nichol ST, Spiropoulou CF, Morzunov S, Rollin PE, Ksiazek TG, Feldmann H, et al. Genetic identification of a hantavirus associated with an outbreak of acute respiratory illness. Science 1993; 262:914 - 7; http://dx.doi.org/10.1126/science.8235615; PMID: 8235615
   PubMed Web of Science ®Google Scholar
• Hjelle B, Torres-Pérez F. Hantaviruses in the americas and their role as emerging pathogens. Viruses 2010; 2:2559 - 86; http://dx.doi.org/10.3390/v2122559; PMID: 21994631
   PubMed Web of Science ®Google Scholar
• Jonsson CB, Hooper J, Mertz G. Treatment of hantavirus pulmonary syndrome. Antiviral Res 2008; 78:162 - 9; http://dx.doi.org/10.1016/j.antiviral.2007.10.012; PMID: 18093668
   PubMed Web of Science ®Google Scholar
• Martinez VP, Bellomo C, San Juan J, Pinna D, Forlenza R, Elder M, et al. Person-to-person transmission of Andes virus. Emerg Infect Dis 2005; 11:1848 - 53; http://dx.doi.org/10.3201/eid1112.050501; PMID: 16485469
   PubMed Web of Science ®Google Scholar
• Schmaljohn C, Hjelle B. Hantaviruses: a global disease problem. Emerg Infect Dis 1997; 3:95 - 104; http://dx.doi.org/10.3201/eid0302.970202; PMID: 9204290
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention (CDC). Hantavirus pulmonary syndrome in visitors to a national park--Yosemite Valley, California, 2012. MMWR Morb Mortal Wkly Rep 2012; 61:952; PMID: 23169317
   PubMedGoogle Scholar
• Dolgin E. Hantavirus treatments advance amidst outbreak in US park. Nat Med 2012; 18:1448; http://dx.doi.org/10.1038/nm1012-1448a; PMID: 23042337
   PubMed Web of Science ®Google Scholar
• Duchin JS, Koster FT, Peters CJ, Simpson GL, Tempest B, Zaki SR, et al, The Hantavirus Study Group. Hantavirus pulmonary syndrome: a clinical description of 17 patients with a newly recognized disease. N Engl J Med 1994; 330:949 - 55; http://dx.doi.org/10.1056/NEJM199404073301401; PMID: 8121458
   PubMed Web of Science ®Google Scholar
• Zaki SR, Greer PW, Coffield LM, Goldsmith CS, Nolte KB, Foucar K, et al. Hantavirus pulmonary syndrome. Pathogenesis of an emerging infectious disease. Am J Pathol 1995; 146:552 - 79; PMID: 7887439
   PubMed Web of Science ®Google Scholar
• Macneil A, Nichol ST, Spiropoulou CF. Hantavirus pulmonary syndrome. Virus Res 2011; 162:138 - 47; http://dx.doi.org/10.1016/j.virusres.2011.09.017; PMID: 21945215
   PubMed Web of Science ®Google Scholar
• Spiropoulou CF, Morzunov S, Feldmann H, Sanchez A, Peters CJ, Nichol ST. Genome structure and variability of a virus causing hantavirus pulmonary syndrome. Virology 1994; 200:715 - 23; http://dx.doi.org/10.1006/viro.1994.1235; PMID: 8178455
   PubMed Web of Science ®Google Scholar
• Spiropoulou CF. Hantavirus maturation. Curr Top Microbiol Immunol 2001; 256:33 - 46; http://dx.doi.org/10.1007/978-3-642-56753-7_3; PMID: 11217405
   PubMed Web of Science ®Google Scholar
• Spiropoulou CF, Goldsmith CS, Shoemaker TR, Peters CJ, Compans RW. Sin Nombre virus glycoprotein trafficking. Virology 2003; 308:48 - 63; http://dx.doi.org/10.1016/S0042-6822(02)00092-2; PMID: 12706089
   PubMed Web of Science ®Google Scholar
• Dietl CA, Wernly JA, Pett SB, Yassin SF, Sterling JP, Dragan R, et al. Extracorporeal membrane oxygenation support improves survival of patients with severe Hantavirus cardiopulmonary syndrome. J Thorac Cardiovasc Surg 2008; 135:579 - 84; http://dx.doi.org/10.1016/j.jtcvs.2007.11.020; PMID: 18329474
   PubMed Web of Science ®Google Scholar
• Khan AS, Khabbaz RF, Armstrong LR, Holman RC, Bauer SP, Graber J, et al. Hantavirus pulmonary syndrome: the first 100 US cases. J Infect Dis 1996; 173:1297 - 303; http://dx.doi.org/10.1093/infdis/173.6.1297; PMID: 8648200
   PubMed Web of Science ®Google Scholar
• Ketai LH, Williamson MR, Telepak RJ, Levy H, Koster FT, Nolte KB, et al. Hantavirus pulmonary syndrome: radiographic findings in 16 patients. Radiology 1994; 191:665 - 8; PMID: 8184043
   PubMed Web of Science ®Google Scholar
• Williams RJ, Bryan RT, Mills JN, Palma RE, Vera I, De Velasquez F, et al. An outbreak of hantavirus pulmonary syndrome in western Paraguay. Am J Trop Med Hyg 1997; 57:274 - 82; PMID: 9311636
   PubMed Web of Science ®Google Scholar
• Castillo C, Naranjo J, Sepúlveda A, Ossa G, Levy H. Hantavirus pulmonary syndrome due to Andes virus in Temuco, Chile: clinical experience with 16 adults. Chest 2001; 120:548 - 54; http://dx.doi.org/10.1378/chest.120.2.548; PMID: 11502657
   PubMed Web of Science ®Google Scholar
• Boroja M, Barrie JR, Raymond GS. Radiographic findings in 20 patients with Hantavirus pulmonary syndrome correlated with clinical outcome. AJR Am J Roentgenol 2002; 178:159 - 63; http://dx.doi.org/10.2214/ajr.178.1.1780159; PMID: 11756112
   PubMed Web of Science ®Google Scholar
• Riquelme R, Riquelme M, Torres A, Rioseco ML, Vergara JA, Scholz L, et al. Hantavirus pulmonary syndrome, southern Chile. Emerg Infect Dis 2003; 9:1438 - 43; http://dx.doi.org/10.3201/eid0911.020798; PMID: 14718088
   PubMed Web of Science ®Google Scholar
• Toro J, Vega JD, Khan AS, Mills JN, Padula P, Terry W, et al. An outbreak of hantavirus pulmonary syndrome, Chile, 1997. Emerg Infect Dis 1998; 4:687 - 94; http://dx.doi.org/10.3201/eid0404.980425; PMID: 9866751
   PubMed Web of Science ®Google Scholar
• Padula P, Martinez VP, Bellomo C, Maidana S, San Juan J, Tagliaferri P, et al. Pathogenic hantaviruses, northeastern Argentina and eastern Paraguay. Emerg Infect Dis 2007; 13:1211 - 4; http://dx.doi.org/10.3201/eid1308.061090; PMID: 17953094
   PubMed Web of Science ®Google Scholar
• Godoy P, Marsac D, Stefas E, Ferrer P, Tischler ND, Pino K, et al. Andes virus antigens are shed in urine of patients with acute hantavirus cardiopulmonary syndrome. J Virol 2009; 83:5046 - 55; http://dx.doi.org/10.1128/JVI.02409-08; PMID: 19279096
   PubMed Web of Science ®Google Scholar
• Peters CJ, Zaki SR. Role of the endothelium in viral hemorrhagic fevers. Crit Care Med 2002; 30:Suppl S268 - 73; http://dx.doi.org/10.1097/00003246-200205001-00016; PMID: 12004247
   PubMed Web of Science ®Google Scholar
• Srikiatkhachorn A, Krautrachue A, Ratanaprakarn W, Wongtapradit L, Nithipanya N, Kalayanarooj S, et al. Natural history of plasma leakage in dengue hemorrhagic fever: a serial ultrasonographic study. Pediatr Infect Dis J 2007; 26:283 - 90, discussion 291-2; http://dx.doi.org/10.1097/01.inf.0000258612.26743.10; PMID: 17414388
   PubMed Web of Science ®Google Scholar
• Srikiatkhachorn A. Plasma leakage in dengue haemorrhagic fever. Thromb Haemost 2009; 102:1042 - 9; PMID: 19967133
   PubMed Web of Science ®Google Scholar
• Tseng CS, Lo HW, Teng HC, Lo WC, Ker CG. Elevated levels of plasma VEGF in patients with dengue hemorrhagic fever. FEMS Immunol Med Microbiol 2005; 43:99 - 102; http://dx.doi.org/10.1016/j.femsim.2004.10.004; PMID: 15607642
   PubMed Web of Science ®Google Scholar
• Dalrymple NA, Mackow ER. Endothelial cells elicit immune-enhancing responses to dengue virus infection. J Virol 2012; 86:6408 - 15; http://dx.doi.org/10.1128/JVI.00213-12; PMID: 22496214
   PubMed Web of Science ®Google Scholar
• Schnittler HJ, Feldmann H. Viral hemorrhagic fever--a vascular disease?. Thromb Haemost 2003; 89:967 - 72; PMID: 12783108
   PubMed Web of Science ®Google Scholar
• Terajima M, Hayasaka D, Maeda K, Ennis FA. Immunopathogenesis of hantavirus pulmonary syndrome and hemorrhagic fever with renal syndrome: Do CD8+ T cells trigger capillary leakage in viral hemorrhagic fevers?. Immunol Lett 2007; 113:117 - 20; http://dx.doi.org/10.1016/j.imlet.2007.08.003; PMID: 17897725
   PubMed Web of Science ®Google Scholar
• Borges AA, Campos GM, Moreli ML, Souza RL, Aquino VH, Saggioro FP, et al. Hantavirus cardiopulmonary syndrome: immune response and pathogenesis. Microbes Infect 2006; 8:2324 - 30; http://dx.doi.org/10.1016/j.micinf.2006.04.019; PMID: 16793309
   PubMed Web of Science ®Google Scholar
• Borges AA, Campos GM, Moreli ML, Moro Souza RL, Saggioro FP, Figueiredo GG, et al. Role of mixed Th1 and Th2 serum cytokines on pathogenesis and prognosis of hantavirus pulmonary syndrome. Microbes Infect 2008; 10:1150 - 7; http://dx.doi.org/10.1016/j.micinf.2008.06.006; PMID: 18606242
   PubMed Web of Science ®Google Scholar
• Koster F, Foucar K, Hjelle B, Scott A, Chong YY, Larson R, et al. Rapid presumptive diagnosis of hantavirus cardiopulmonary syndrome by peripheral blood smear review. Am J Clin Pathol 2001; 116:665 - 72; http://dx.doi.org/10.1309/CNWF-DC72-QYMR-M8DA; PMID: 11710682
   PubMed Web of Science ®Google Scholar
• Markotić A, Hensley L, Daddario K, Spik K, Anderson K, Schmaljohn C. Pathogenic hantaviruses elicit different immunoreactions in THP-1 cells and primary monocytes and induce differentiation of human monocytes to dendritic-like cells. Coll Antropol 2007; 31:1159 - 67; PMID: 18217475
   PubMed Web of Science ®Google Scholar
• Temonen M, Vapalahti O, Holthöfer H, Brummer-Korvenkontio M, Vaheri A, Lankinen H. Susceptibility of human cells to Puumala virus infection. J Gen Virol 1993; 74:515 - 8; http://dx.doi.org/10.1099/0022-1317-74-3-515; PMID: 8445370
   PubMed Web of Science ®Google Scholar
• Raftery MJ, Kraus AA, Ulrich R, Krüger DH, Schönrich G. Hantavirus infection of dendritic cells. J Virol 2002; 76:10724 - 33; http://dx.doi.org/10.1128/JVI.76.21.10724-10733.2002; PMID: 12368315
   PubMed Web of Science ®Google Scholar
• Jenison S, Yamada T, Morris C, Anderson B, Torrez-Martinez N, Keller N, et al. Characterization of human antibody responses to four corners hantavirus infections among patients with hantavirus pulmonary syndrome. J Virol 1994; 68:3000 - 6; PMID: 7512156
   PubMed Web of Science ®Google Scholar
• Valdivieso F, Vial P, Ferres M, Ye C, Goade D, Cuiza A, et al. Neutralizing antibodies in survivors of Sin Nombre and Andes hantavirus infection. Emerg Infect Dis 2006; 12:166 - 8; http://dx.doi.org/10.3201/eid1201.050930; PMID: 16494739
   PubMed Web of Science ®Google Scholar
• Bharadwaj M, Nofchissey R, Goade D, Koster F, Hjelle B. Humoral immune responses in the hantavirus cardiopulmonary syndrome. J Infect Dis 2000; 182:43 - 8; http://dx.doi.org/10.1086/315657; PMID: 10882580
   PubMed Web of Science ®Google Scholar
• MacNeil A, Comer JA, Ksiazek TG, Rollin PE. Sin Nombre virus-specific immunoglobulin M and G kinetics in hantavirus pulmonary syndrome and the role played by serologic responses in predicting disease outcome. J Infect Dis 2010; 202:242 - 6; http://dx.doi.org/10.1086/653482; PMID: 20521946
   PubMed Web of Science ®Google Scholar
• Mori M, Rothman AL, Kurane I, Montoya JM, Nolte KB, Norman JE, et al. High levels of cytokine-producing cells in the lung tissues of patients with fatal hantavirus pulmonary syndrome. J Infect Dis 1999; 179:295 - 302; http://dx.doi.org/10.1086/314597; PMID: 9878011
   PubMed Web of Science ®Google Scholar
• Sundstrom JB, McMullan LK, Spiropoulou CF, Hooper WC, Ansari AA, Peters CJ, et al. Hantavirus infection induces the expression of RANTES and IP-10 without causing increased permeability in human lung microvascular endothelial cells. J Virol 2001; 75:6070 - 85; http://dx.doi.org/10.1128/JVI.75.13.6070-6085.2001; PMID: 11390609
   PubMed Web of Science ®Google Scholar
• Khaiboullina SF, St Jeor SC. Hantavirus immunology. Viral Immunol 2002; 15:609 - 25; http://dx.doi.org/10.1089/088282402320914548; PMID: 12513931
   PubMed Web of Science ®Google Scholar
• Khaiboullina SF, Rizvanov AA, Deyde VM, St Jeor SC. Andes virus stimulates interferon-inducible MxA protein expression in endothelial cells. J Med Virol 2005; 75:267 - 75; http://dx.doi.org/10.1002/jmv.20266; PMID: 15602733
   PubMed Web of Science ®Google Scholar
• Geimonen E, Neff S, Raymond T, Kocer SS, Gavrilovskaya IN, Mackow ER. Pathogenic and nonpathogenic hantaviruses differentially regulate endothelial cell responses. Proc Natl Acad Sci U S A 2002; 99:13837 - 42; http://dx.doi.org/10.1073/pnas.192298899; PMID: 12368479
   PubMed Web of Science ®Google Scholar
• Marsac D, García S, Fournet A, Aguirre A, Pino K, Ferres M, et al. Infection of human monocyte-derived dendritic cells by ANDES Hantavirus enhances pro-inflammatory state, the secretion of active MMP-9 and indirectly enhances endothelial permeability. Virol J 2011; 8:223; http://dx.doi.org/10.1186/1743-422X-8-223; PMID: 21569520
   PubMed Web of Science ®Google Scholar
• Manigold T, Mori A, Graumann R, Llop E, Simon V, Ferrés M, et al. Highly differentiated, resting gn-specific memory CD8+ T cells persist years after infection by andes hantavirus. PLoS Pathog 2010; 6:e1000779; http://dx.doi.org/10.1371/journal.ppat.1000779; PMID: 20174562
   PubMed Web of Science ®Google Scholar
• Ennis FA, Cruz J, Spiropoulou CF, Waite D, Peters CJ, Nichol ST, et al. Hantavirus pulmonary syndrome: CD8+ and CD4+ cytotoxic T lymphocytes to epitopes on Sin Nombre virus nucleocapsid protein isolated during acute illness. Virology 1997; 238:380 - 90; http://dx.doi.org/10.1006/viro.1997.8827; PMID: 9400611
   PubMed Web of Science ®Google Scholar
• Kilpatrick ED, Terajima M, Koster FT, Catalina MD, Cruz J, Ennis FA. Role of specific CD8+ T cells in the severity of a fulminant zoonotic viral hemorrhagic fever, hantavirus pulmonary syndrome. J Immunol 2004; 172:3297 - 304; PMID: 14978138
   PubMed Web of Science ®Google Scholar
• Borges AA, Donadi EA, Campos GM, Moreli ML, de Sousa RL, Saggioro FP, et al. Association of -308G/A polymorphism in the tumor necrosis factor-alpha gene promoter with susceptibility to development of hantavirus cardiopulmonary syndrome in the Ribeirão Preto region, Brazil. Arch Virol 2010; 155:971 - 5; http://dx.doi.org/10.1007/s00705-010-0655-7; PMID: 20372945
   PubMed Web of Science ®Google Scholar
• Shrivastava-Ranjan P, Rollin PE, Spiropoulou CF. Andes virus disrupts the endothelial cell barrier by induction of vascular endothelial growth factor and downregulation of VE-cadherin. J Virol 2010; 84:11227 - 34; http://dx.doi.org/10.1128/JVI.01405-10; PMID: 20810734
   PubMed Web of Science ®Google Scholar
• Gavrilovskaya IN, Gorbunova EE, Mackow ER. Pathogenic hantaviruses direct the adherence of quiescent platelets to infected endothelial cells. J Virol 2010; 84:4832 - 9; http://dx.doi.org/10.1128/JVI.02405-09; PMID: 20181715
   PubMed Web of Science ®Google Scholar
• Gavrilovskaya IN, Gorbunova EE, Mackow NA, Mackow ER. Hantaviruses direct endothelial cell permeability by sensitizing cells to the vascular permeability factor VEGF, while angiopoietin 1 and sphingosine 1-phosphate inhibit hantavirus-directed permeability. J Virol 2008; 82:5797 - 806; http://dx.doi.org/10.1128/JVI.02397-07; PMID: 18367532
   PubMed Web of Science ®Google Scholar
• Gavrilovskaya I, Gorbunova E, Koster F, Mackow E. Elevated VEGF Levels in Pulmonary Edema Fluid and PBMCs from Patients with Acute Hantavirus Pulmonary Syndrome. Adv Virol 2012; 2012:674360; http://dx.doi.org/10.1155/2012/674360; PMID: 22956954
   PubMedGoogle Scholar
• Lampugnani MG, Dejana E. The control of endothelial cell functions by adherens junctions. Novartis Found Symp 2007; 283:4 - 13, discussion 13-7, 238-41; http://dx.doi.org/10.1002/9780470319413.ch2; PMID: 18300410
   PubMedGoogle Scholar
• Taddei A, Giampietro C, Conti A, Orsenigo F, Breviario F, Pirazzoli V, et al. Endothelial adherens junctions control tight junctions by VE-cadherin-mediated upregulation of claudin-5. Nat Cell Biol 2008; 10:923 - 34; http://dx.doi.org/10.1038/ncb1752; PMID: 18604199
   PubMed Web of Science ®Google Scholar
• Dejana E, Tournier-Lasserve E, Weinstein BM. The control of vascular integrity by endothelial cell junctions: molecular basis and pathological implications. Dev Cell 2009; 16:209 - 21; http://dx.doi.org/10.1016/j.devcel.2009.01.004; PMID: 19217423
   PubMed Web of Science ®Google Scholar
• Gavard J. Breaking the VE-cadherin bonds. FEBS Lett 2009; 583:1 - 6; http://dx.doi.org/10.1016/j.febslet.2008.11.032; PMID: 19059243
   PubMed Web of Science ®Google Scholar
• Gavard J, Gutkind JS. VEGF controls endothelial-cell permeability by promoting the beta-arrestin-dependent endocytosis of VE-cadherin. Nat Cell Biol 2006; 8:1223 - 34; http://dx.doi.org/10.1038/ncb1486; PMID: 17060906
   PubMed Web of Science ®Google Scholar
• Dejana E, Orsenigo F, Lampugnani MG. The role of adherens junctions and VE-cadherin in the control of vascular permeability. J Cell Sci 2008; 121:2115 - 22; http://dx.doi.org/10.1242/jcs.017897; PMID: 18565824
   PubMed Web of Science ®Google Scholar
• Gorbunova E, Gavrilovskaya IN, Mackow ER. Pathogenic hantaviruses Andes virus and Hantaan virus induce adherens junction disassembly by directing vascular endothelial cadherin internalization in human endothelial cells. J Virol 2010; 84:7405 - 11; http://dx.doi.org/10.1128/JVI.00576-10; PMID: 20463083
   PubMed Web of Science ®Google Scholar
• Gorbunova EE, Gavrilovskaya IN, Pepini T, Mackow ER. VEGFR2 and Src kinase inhibitors suppress Andes virus-induced endothelial cell permeability. J Virol 2011; 85:2296 - 303; http://dx.doi.org/10.1128/JVI.02319-10; PMID: 21177802
   PubMed Web of Science ®Google Scholar
• Gavard J, Patel V, Gutkind JS. Angiopoietin-1 prevents VEGF-induced endothelial permeability by sequestering Src through mDia. Dev Cell 2008; 14:25 - 36; http://dx.doi.org/10.1016/j.devcel.2007.10.019; PMID: 18194650
   PubMed Web of Science ®Google Scholar
• Rowe RK, Pekosz A. Bidirectional virus secretion and nonciliated cell tropism following Andes virus infection of primary airway epithelial cell cultures. J Virol 2006; 80:1087 - 97; http://dx.doi.org/10.1128/JVI.80.3.1087-1097.2006; PMID: 16414986
   PubMed Web of Science ®Google Scholar
• Spiropoulou CF, Albariño CG, Ksiazek TG, Rollin PE. Andes and Prospect Hill hantaviruses differ in early induction of interferon although both can downregulate interferon signaling. J Virol 2007; 81:2769 - 76; http://dx.doi.org/10.1128/JVI.02402-06; PMID: 17202220
   PubMed Web of Science ®Google Scholar
• Levine JR, Prescott J, Brown KS, Best SM, Ebihara H, Feldmann H. Antagonism of type I interferon responses by new world hantaviruses. J Virol 2010; 84:11790 - 801; http://dx.doi.org/10.1128/JVI.00916-10; PMID: 20844031
   PubMed Web of Science ®Google Scholar
• Temonen M, Lankinen H, Vapalahti O, Ronni T, Julkunen I, Vaheri A. Effect of interferon-alpha and cell differentiation on Puumala virus infection in human monocyte/macrophages. Virology 1995; 206:8 - 15; http://dx.doi.org/10.1016/S0042-6822(95)80014-X; PMID: 7831843
   PubMed Web of Science ®Google Scholar
• Temonen M, Mustonen J, Helin H, Pasternack A, Vaheri A, Holthöfer H. Cytokines, adhesion molecules, and cellular infiltration in nephropathia epidemica kidneys: an immunohistochemical study. Clin Immunol Immunopathol 1996; 78:47 - 55; http://dx.doi.org/10.1006/clin.1996.0007; PMID: 8599883
   PubMedGoogle Scholar
• Markotic A, Hensley L, Geisbert T, Spik K, Schmaljohn C. Hantaviruses induce cytopathic effects and apoptosis in continuous human embryonic kidney cells. J Gen Virol 2003; 84:2197 - 202; http://dx.doi.org/10.1099/vir.0.19090-0; PMID: 12867652
   PubMed Web of Science ®Google Scholar
• Cebalo L, Markotić A. Chemokine production predominates in human monocytes infected with Tula virus. Viral Immunol 2007; 20:206 - 13; http://dx.doi.org/10.1089/vim.2006.0039; PMID: 17425435
   PubMed Web of Science ®Google Scholar
• Bambace NM, Levis JE, Holmes CE. The effect of P2Y-mediated platelet activation on the release of VEGF and endostatin from platelets. Platelets 2010; 21:85 - 93; http://dx.doi.org/10.3109/09537100903470298; PMID: 20063989
   PubMed Web of Science ®Google Scholar
• Terajima M, Vapalahti O, Van Epps HL, Vaheri A, Ennis FA. Immune responses to Puumala virus infection and the pathogenesis of nephropathia epidemica. Microbes Infect 2004; 6:238 - 45; http://dx.doi.org/10.1016/j.micinf.2003.10.017; PMID: 15049335
   PubMed Web of Science ®Google Scholar
• Suidan GL, Dickerson JW, Chen Y, McDole JR, Tripathi P, Pirko I, et al. CD8 T cell-initiated vascular endothelial growth factor expression promotes central nervous system vascular permeability under neuroinflammatory conditions. J Immunol 2010; 184:1031 - 40; http://dx.doi.org/10.4049/jimmunol.0902773; PMID: 20008293
   PubMed Web of Science ®Google Scholar